Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 138 for “"Graft function"”.
-
Immunologic Risk Prediction Model for Kidney Graft Function
… levels are the most common methods of monitoring graft function after transplant; however, they have several negative aspects. Use of traditional factors regarding donors and recipients such as Human Leukocyte Antigen (HLA) DNA typing, pre-transplant anti-HLA antibody levels, and basic …
-
Predicting and ameliorating graft function in deceased donor kidney transplantation
… waiting lists (2-4) but greater variability in graft outcomes. The ability to predict transplant outcomes has therefore become increasingly important as the use of ‘higher risk’ donors results in poorer graft outcomes (5). In particular, expansion of the donor pool has resulted in inferior early …
-
Biomarkers of acute kidney injury and delayed graft function. Structure, function, and the effect of treatment
… creatinine (sCr) and oliguria are the current functional criteria for recognising acute kidney injury (AKI) including AKI causing delayed graft function (DGF) and slow graft function (SGF) following kidney transplantation. However, there are limitations to GFR reduction as a marker of AKI or …
-
1H NMR spectroscopic identification of non-invasive biomarkers of acute rejection and delayed graft function in renal transplantation
Delayed graft function (DGF) and acute rejection (AR) are complications after renal transplantation. It is impossible to differentiate between these clinically. Renal biopsy is the gold standard for diagnosis but is invasive and associated with complications. We aimed to identify early biomarkers, …
-
BioPAsSPoRT: Biomarkers for Patient Assessment and Stratification Post Renal Transplant
… scarce. In order to expand the pool of available grafts, extended criteria donations are increasingly being used but these come with increased rates of complications such as delayed graft function. Currently delayed graft function is defined as the need for dialysis in the first week after …
-
Propuesta de un nuevo biomarcador para los trasplantados renales sobre la base del estudio de tecnologias de salud codependientes
… transplant recipients, the stability of kidney graft function, defined as a low frequency of acute allograft dysfunction (AAD) events. To date, only serum creatinine measurement is available for the evaluation of kidney graft function. Our findings affirm that the number of Tregs in the …
-
Durchflusszytometrisch gemessene CD8 T-Zellen und Tubulusepithelzellen als Urin-Biomarker für Nierentransplantat-Abstoßung
… mit „Guter Transplantatunktion“ (engl. Good Graft Function) und „Verzögerter Transplantatfunktion“ (engl. Delayed Graft Function“) bis zu 110 Tage nach Transplantation untersucht. In einer Querschnittskohorte (n = 63) wurden Patienten mit Verdacht auf Abstoßung biopsiert und anhand der …
-
Einflussfaktoren auf Transplantatüberleben und Transplantatfunktion nach Nierenlebendspende in Abhängigkeit der Sequenz Lebendspende-Kadaverspende versus Kadaverspende-Lebendspende
Since allograft survival is limited after living-related kidney transplantation (LRKT), the necessity of re-transplantation following LRKT increases. Information using living-related- versus deceased donor allografts is sparse. The outcome after kidney re-transplantation in respect to second graft …
-
Characterising complement behaviour and inhibition in normothermic machine perfusion for renal transplantation
… limited by ischaemia-reperfusion injury, delayed graft function, and the restricted ability to assess or treat organs before implantation. Normothermic machine perfusion (NMP) has emerged as a promising preservation strategy that may support organ assessment, prolong preservation, and provide a …
-
Donor Specific Antibody Surveillance and Graft Outcomes in Pediatric Kidney Transplant Recipients
… (dnDSA) has been associated with rejection and graft loss in kidney transplantation, and DSA screening is now recommended in all kidney transplant recipients. However, the clinical significance of dnDSA in patients with a stable creatinine remains unclear. Methods: We performed a retrospective …
-
Μελέτη των γενετικών πολυμορφισμών του γονιδίου της αιμοξυγενασης-1 (HO-1) και επίδραση τους σε καταστάσεις οξειδωτικού στρες
… of donor’s and recipient’s genotype in the graft survival and function after kidney transplantation, as well as on clinical outcome in 175 transplantation procedures. We also estimate the frequencies of alleles with varying numbers of (GT)n repeats in 250 healthy Greek individuals. Complete …
-
Η επίδραση της ηλικίας δότη νεφρού στη λειτουργία του νεφρικού μοσχεύματος
… A: Over aged recipients (>60 years) receiving a graft from over aged donors (>60 years). Group B: Over aged recipients (>60 years) receiving a graft from donors under 60 years. Group C: Recipients under 60 years receiving a graft from over aged donors. Group D: Recipients under 60 years receiving …
-
Tailored Immunosuppression for Kidney Transplant Recipients
… increasing the risk of acute rejection or graft failure. Anecdotally, some clinicians use risk factors for rejection or graft failure to identify recipients appropriate for ESW. However, there is no consensus or clinical evidence on what patients are appropriate for ESW. In this …
-
GRAFT - Generic Rating of Allograft Function Post Transplant
… transplantation. Measuring the post-transplant function of these organs – good or bad – represents an attractive way of deciding whether treatment of deceased donors is working well, or not so well. Function, however, is organ-specific. Therefore, to conduct the most efficient and informative …
-
Effect of Cinacalcet therapy on surgical outcome in patients with renal hyperparathyroidism
… mortality, and impairment of kidney graft function are the main problems of renal HPT. Modern therapy of renal HPT consists of administration of active forms of Vitamin D and phosphate binders; since 2004 a target therapy with cinacalcet, an allosteric modulator of calcium sensing …
Page 1 of 7